{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-022255","form_type":"8-K","ticker":"SXT","cik":"0000310142","company_name":"SENSIENT TECHNOLOGIES CORP","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.508711+00:00","generated_at":"2026-06-03T06:46:44.042280+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sensient Q1 revenue up 4.2%; raises 2024 guidance to mid-single-digit growth","bullets":["Q1 revenue $384.7M (+4.2% reported; +3.8% local currency); reported EPS $0.73 vs $0.80 YoY.","Adjusted local currency EPS declined 1.3%; local currency adjusted operating income up 2.6%.","Flavors & Extracts revenue +8.0% (local currency +6.9%); Color revenue -0.7% on pharma destocking.","Now expects 2024 revenue and adjusted EBITDA to grow at mid-single-digit rate (prior: low to mid-single-digit).","GAAP EPS guidance $2.80-$2.90 includes $0.15 of Portfolio Optimization Plan costs; adjusted EPS growth low to mid-single-digit."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-022255","json":"https://secwatch.observer/filing/0001140361-24-022255.json","markdown":"https://secwatch.observer/filing/0001140361-24-022255.md","text":"https://secwatch.observer/filing/0001140361-24-022255.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310142/000114036124022255/0001140361-24-022255-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310142/000114036124022255/ef20027679_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:46:44.042280+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58e4336e55f96131c8d8fe8811c6ae111f4801a2","claim":"SENSIENT TECHNOLOGIES CORP reported the quarter ended March 31, 2024 results: revenue $384.7 million, EPS 73 cents. Guidance raised.","evidence_excerpt":"and personal care markets, today reported financial results for the first quarter ended March 31, 2024. First Quarter Consolidated Results • Reported revenue increased 4.2% to $384.7 million in the first quarter of 2024 versus last year’s first quarter results of $369.0 million. On a local currency basis (1) , revenue increased 3.8%. • Reported operating income","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310142/000114036124022255/0001140361-24-022255-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"$384.7 million"},{"label":"EPS","value":"73 cents"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}